Collins Helen Louise 4
4 · Enliven Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-02-13+185,000→ 185,000 totalExercise: $14.85Exp: 2034-02-12→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.